The NHGRI GWAS catalog [50] (accessed on 17th September 2014) identified 21 published GWAS linking TERT to breast cancer, bladder cancer, testicular cancer, lung cancer, glioma and prostate cancer and 11 GWAS linking FGFR2 to breast cancer. Here, FGFR2 is linked to prostate carcinoma.